Otsuka Pharmaceutical Co., Ltd (TYO: 4578), abbreviated OPC, is a pharmaceutical company ... Otsuka's subsidiary Otsuka America will pay $100 million upfront for Neurovance, plus up-to $150 million in development and approval milestones ...


Otsuka in the U.S. From a family business to a global pharmaceutical business. Research and development of new pharmaceutical products and Digital Medicine. Fulfil your ... Otsuka Pharmaceutical Development & Commercialization, Inc.


Otsuka America Pharmaceutical, Inc. (OAPI) brings new medicines to market. OAPI commercializes Otsuka-developed and in-licensed products for use in ...


Otsuka in the U.S. has two companies that carry out research, clinical development and commercialization of ... Otsuka America Pharmaceutical, Inc. ( OAPI).


Otsuka in the U.S. offers a wide variety of careers in pharma. Examples of specialist areas includes ... Otsuka America Pharmaceutical, Inc. 2440 Research Blvd ...


OTSUKA IN THE U.S. ... Otsuka America Pharmaceutical, Inc. 2440 Research Blvd, Rockville, ... Otsuka Pharmaceutical Development & Commercialization, Inc .


Otsuka America Pharmaceutical, Inc., (OAPI) commercializes Otsuka-discovered and in-licensed products in the United States; its Canadian subsidiary, Otsuka ...


Corporate Headquarters/General Inquiries. Otsuka America Pharmaceutical, Inc. Rockville, MD 20850 USA (301) 990-0030 phone; (800) 562-3974 toll free


We have numerous promising drugs currently in the pipeline. In conjunction with Otsuka America Pharmaceutical, Inc, (OAPI), we have global strategies in place ...